AGA acknowledges partnership of GCF to aid study in gastric.

AGA acknowledges partnership of GCF to aid study in gastric, esophageal cancer The American Gastroenterological Association Research Base is very happy to announce that it has partnered with the Gastric Cancer Base to make a new grant to support research in gastric and esophageal cancer. The AGA Institute will match GCF's dedication of $1 prescription medication .125 million, producing a $2.25 million endowment to invest in young investigators whose research will enhance the fundamental understanding of gastric and esophageal cancer pathobiology in order to ultimately prevent or create a cure for these diseases. Related StoriesViralytics enters into scientific trial collaboration agreement with MSDStudy shows uncommon HER2 missense mutations usually do not spread breast cancer on the ownCornell biomedical engineers develop 'super organic killer cells' to destroy tumor cells in lymph nodes We are very happy to join with the Gastric Cancer tumor Basis to create this new research scholar award in gastric and esophageal tumor, stated Martin Brotman, MD, AGAF, chair, AGA Analysis Foundation.